Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08VXD
|
|||
| Drug Name |
CGF166
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Deafness [ICD-11: AB52] | Phase 1/2 | [1] | |
| Company |
Novartis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02132130) Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.